|56.52||+1.39 / +2.52%|
Data as of 4:00pm ET
|56.29||-0.23 / -0.41%|
The 6 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 64.50, with a high estimate of 75.00 and a low estimate of 43.00. The median estimate represents a +14.12% increase from the last price of 56.52.
The current consensus among 7 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.